- Home
- POAI vs SISI Comparison
POAI vs SISI Comparison
Compare POAI & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SISI
- Stock Information
- Founded
- POAI 2002
- SISI 1997
- Country
- POAI United States
- SISI China
- Employees
- POAI N/A
- SISI N/A
- Industry
- POAI Industrial Specialties
- SISI Medicinal Chemicals and Botanical Products
- Sector
- POAI Health Care
- SISI Health Care
- Exchange
- POAI Nasdaq
- SISI Nasdaq
- Market Cap
- POAI 7.8M
- SISI 6.5M
- IPO Year
- POAI N/A
- SISI 2016
- Fundamental
- Price
- POAI $0.85
- SISI $5.59
- Analyst Decision
- POAI Hold
- SISI
- Analyst Count
- POAI 1
- SISI 0
- Target Price
- POAI N/A
- SISI N/A
- AVG Volume (30 Days)
- POAI 168.6K
- SISI 266.6K
- Earning Date
- POAI 08-19-2025
- SISI 09-29-2025
- Dividend Yield
- POAI N/A
- SISI N/A
- EPS Growth
- POAI N/A
- SISI N/A
- EPS
- POAI N/A
- SISI N/A
- Revenue
- POAI $1,729,269.00
- SISI $9,601,324.00
- Revenue This Year
- POAI $486.27
- SISI N/A
- Revenue Next Year
- POAI $65.50
- SISI N/A
- P/E Ratio
- POAI N/A
- SISI N/A
- Revenue Growth
- POAI 24.17
- SISI 1133.26
- 52 Week Low
- POAI $0.55
- SISI $4.96
- 52 Week High
- POAI $3.06
- SISI $852.00
- Technical
- Relative Strength Index (RSI)
- POAI 47.32
- SISI 30.48
- Support Level
- POAI $0.71
- SISI $6.10
- Resistance Level
- POAI $0.82
- SISI $7.15
- Average True Range (ATR)
- POAI 0.05
- SISI 1.21
- MACD
- POAI 0.00
- SISI 0.06
- Stochastic Oscillator
- POAI 63.73
- SISI 0.34
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.